Skip to content

Efficacy and safety of Combined Catheter Ablation for AF and LAA Occlusion procedures

Efficacy and safety of Combined Catheter Ablation for AF and LAA Occlusion procedures

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-17011530
Enrollment
Unknown
Registered
2017-05-31
Start date
2017-06-01
Completion date
Unknown
Last updated
2017-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation

Interventions

1:Combined atrial fibrillation catheter ablation and left atrial appendage occlusion procedure

Sponsors

Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Chinese people aged 65-85 year-old; 2. Paroxysmal atrial fibrillation or persistent atrial fibrillation lasting for less than 3 years; 3. No previous histroy of atrial fibrillation catheter ablation; 4. CHA2DS2-VASc risk score of 2 or more; 5. Have signed the informed consent; 6. Be willing and be able to finish the follow-up visit as scheduled.

Exclusion criteria

Exclusion criteria: 1. Have a history of left atrial catheter ablation or surgical ablation; 2. Structural heart disease, including congenital heart disease, cardiac valve disease (moderate or severe, or prior metallic prosthetic heart valve replacement), hypertrophic cardiomyopathy; 3. Reversible causes of AF including but not limited to hyperthyroidism; 4. Myocardial infarction within 3 months prior to enrollment; 5. Patient has contra-indication to oral anticoagulation, heparin or low molecular weight heparins; 6. Left atrial diameter = 60 mm (2D echocardiography, parasternal long axis view); 7. Life expectancy = 2 years due to all kinds of reasons; 8. Abnormal liver or renal function; 9. High risk of accidental falls; 10. Low Treatment compliance; 11. Symptomatic carotid artery disease; 12. Need long term anticoagulation for reasons other than atrial fibrillation; 13. Proved to have thrombus, tumor or other disease that might affect the catheter placement in the atrium.

Design outcomes

Primary

MeasureTime frame
1-year all-cause mortality post procedure;1-year ischemic stroke rate post procedure;1-year systemic embolism rate post procedure;

Secondary

MeasureTime frame
The occurrence of bleeding in 1 year post procedure;The time free from any AF/AT (ECG confirmed) without AADs (except for ß blockers) between the 3rd month to the 12th month post procedure;

Countries

China

Contacts

Public ContactChenyang Jiang

Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University

jiangchenyangmail@163.com+86 13857190051

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026